FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082016809> ?p ?o ?g. }

• W3082016809 endingPage "135" @default.
• W3082016809 startingPage "127" @default.
• W3082016809 abstract "Immunohistochemical stains have been suggested to aid in diagnostically challenging cases of urothelial carcinoma in-situ (CIS). Although full thickness immunostaining for CK20 is supportive of CIS, a subset of CIS cases is CK20(−), the clinical significance of which was unknown. This study included 43 patients with primary diagnosis of bladder CIS including 32 with only CIS, 5 with CIS and separate noninvasive high-grade papillary urothelial carcinoma, and 6 with CIS and separate high-grade urothelial carcinoma with lamina propria invasion. Digital morphometric image analysis showed that the average nuclear areas of enlarged nuclei were similar in CK20(+) and CK20(−) CIS (26.9 vs. 24.5 µM 2 ; P =0.31). Average Ki67 index for CK20(+) CIS was higher than CK20(−) CIS (31.1% vs. 18.3%; P =0.03). Patients with CK20(+) CIS [28 (65%)] and patients with CK20(−) CIS [15 (35%)] had the same rates of Bacillus Calmete-Guerin (BCG) failure but patients with CK20(−) CIS had higher stage progression [3 CK20(+) (11%) vs. 6 CK20(−) (40%); P =0.02]. Given recent approval of immune checkpoint inhibitors in patients with CIS refractory to BCG, programmed death ligand-1 expression and colocalization with CD8(+) lymphocytes was investigated as signature of adaptive immune response and was seen in 8 patients regardless of CK20 status and exclusively among patients who failed BCG. Our results confirm that negative CK20 IHC does not exclude CIS and that those patients have similar clinical outcomes as patients with CK20(+) CIS. Programmed death ligand-1 and CD8 colocalization seen among patients who failed BCG therapy is an easy assay to perform to identify patients who could potentially benefit from combined BCG therapy and immune checkpoint inhibition." @default.
• W3082016809 created "2020-09-08" @default.
• W3082016809 creator A5001308517 @default.
• W3082016809 creator A5002892743 @default.
• W3082016809 creator A5027033402 @default.
• W3082016809 creator A5037573167 @default.
• W3082016809 creator A5044979250 @default.
• W3082016809 creator A5047701478 @default.
• W3082016809 creator A5059536506 @default.
• W3082016809 creator A5077350606 @default.
• W3082016809 creator A5078160360 @default.
• W3082016809 creator A5083157531 @default.
• W3082016809 creator A5086192559 @default.
• W3082016809 date "2020-08-28" @default.
• W3082016809 modified "2023-09-29" @default.
• W3082016809 title "Urothelial Carcinoma In Situ of the Bladder: Correlation of CK20 Expression With Adaptive Immune Resistance, Response to BCG Therapy, and Clinical Outcome" @default.
• W3082016809 cites W1982396121 @default.
• W3082016809 cites W2016221237 @default.
• W3082016809 cites W2020124294 @default.
• W3082016809 cites W2025574033 @default.
• W3082016809 cites W2035107439 @default.
• W3082016809 cites W2036531978 @default.
• W3082016809 cites W2049934605 @default.
• W3082016809 cites W2052040125 @default.
• W3082016809 cites W2057893793 @default.
• W3082016809 cites W2072588428 @default.
• W3082016809 cites W2094868158 @default.
• W3082016809 cites W2270022169 @default.
• W3082016809 cites W2328754361 @default.
• W3082016809 cites W2340636398 @default.
• W3082016809 cites W2395763454 @default.
• W3082016809 cites W2412492782 @default.
• W3082016809 cites W2414199713 @default.
• W3082016809 cites W2415382229 @default.
• W3082016809 cites W2622957603 @default.
• W3082016809 cites W2760139092 @default.
• W3082016809 cites W2763405903 @default.
• W3082016809 cites W2944104819 @default.
• W3082016809 cites W2968421234 @default.
• W3082016809 cites W2984806521 @default.
• W3082016809 cites W3010116910 @default.
• W3082016809 cites W3010396552 @default.
• W3082016809 cites W4233280187 @default.
• W3082016809 doi "https://doi.org/10.1097/pai.0000000000000872" @default.
• W3082016809 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7878196" @default.
• W3082016809 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32858539" @default.
• W3082016809 hasPublicationYear "2020" @default.
• W3082016809 type Work @default.
• W3082016809 sameAs 3082016809 @default.
• W3082016809 citedByCount "4" @default.
• W3082016809 countsByYear W30820168092021 @default.
• W3082016809 countsByYear W30820168092022 @default.
• W3082016809 countsByYear W30820168092023 @default.
• W3082016809 crossrefType "journal-article" @default.
• W3082016809 hasAuthorship W3082016809A5001308517 @default.
• W3082016809 hasAuthorship W3082016809A5002892743 @default.
• W3082016809 hasAuthorship W3082016809A5027033402 @default.
• W3082016809 hasAuthorship W3082016809A5037573167 @default.
• W3082016809 hasAuthorship W3082016809A5044979250 @default.
• W3082016809 hasAuthorship W3082016809A5047701478 @default.
• W3082016809 hasAuthorship W3082016809A5059536506 @default.
• W3082016809 hasAuthorship W3082016809A5077350606 @default.
• W3082016809 hasAuthorship W3082016809A5078160360 @default.
• W3082016809 hasAuthorship W3082016809A5083157531 @default.
• W3082016809 hasAuthorship W3082016809A5086192559 @default.
• W3082016809 hasBestOaLocation W30820168092 @default.
• W3082016809 hasConcept C121608353 @default.
• W3082016809 hasConcept C126322002 @default.
• W3082016809 hasConcept C142724271 @default.
• W3082016809 hasConcept C143998085 @default.
• W3082016809 hasConcept C204232928 @default.
• W3082016809 hasConcept C2777546739 @default.
• W3082016809 hasConcept C2777661416 @default.
• W3082016809 hasConcept C2780352672 @default.
• W3082016809 hasConcept C4224716 @default.
• W3082016809 hasConcept C71924100 @default.
• W3082016809 hasConceptScore W3082016809C121608353 @default.
• W3082016809 hasConceptScore W3082016809C126322002 @default.
• W3082016809 hasConceptScore W3082016809C142724271 @default.
• W3082016809 hasConceptScore W3082016809C143998085 @default.
• W3082016809 hasConceptScore W3082016809C204232928 @default.
• W3082016809 hasConceptScore W3082016809C2777546739 @default.
• W3082016809 hasConceptScore W3082016809C2777661416 @default.
• W3082016809 hasConceptScore W3082016809C2780352672 @default.
• W3082016809 hasConceptScore W3082016809C4224716 @default.
• W3082016809 hasConceptScore W3082016809C71924100 @default.
• W3082016809 hasIssue "2" @default.
• W3082016809 hasLocation W30820168091 @default.
• W3082016809 hasLocation W30820168092 @default.
• W3082016809 hasLocation W30820168093 @default.
• W3082016809 hasOpenAccess W3082016809 @default.
• W3082016809 hasPrimaryLocation W30820168091 @default.
• W3082016809 hasRelatedWork W1964517198 @default.
• W3082016809 hasRelatedWork W2022498945 @default.
• W3082016809 hasRelatedWork W202920663 @default.
• W3082016809 hasRelatedWork W2031345631 @default.
• W3082016809 hasRelatedWork W2079153990 @default.
• W3082016809 hasRelatedWork W2084136175 @default.

• next